Skip to main content
TipRanks
Go Ultimate75% OFF

BioMarin Pharmaceutical (BM8) Q2 2026 Earnings Report

1 Followers

DE:BM8 Q2 2026 EPS Results

Actual EPS
EUR 1.08
Consensus EPS
EUR 0.86
Beat/Miss
Beat by +EUR 0.23
One Year Ago EPS
EUR 1.11

DE:BM8 Q2 2026 Revenue Results

Actual Revenue
EUR 900.66M
Expected Revenue
EUR 842.49M
Beat/Miss
Beat by +EUR 58.17M
YoY Revenue Growth
+20.41%

Earnings Announcement Details

Quarter
Q2 2026
Date
08/06/2026
Time
After Close
Conference Call
Thursday, August 6, 2026
DE:BM8 Upcoming Earnings

BioMarin Pharmaceutical's next earnings date is estimated for February 24, 2027, based on past reporting schedules.

Q2 2026 Earnings Call Audio

DE:BM8 Q2 2026 Earnings Call
0:00 / 0:00

Q2 2026 Earnings Slide Deck

Q2 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:BM8 Earnings History

DE:BM8 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 24, 20272026 (Q4)0.74--0.22――
Nov 02, 20262026 (Q3)-0.040.21-0.14243.75% (+0.35)
Aug 06, 20262026 (Q2)0.861.081.11-2.44% (-0.03)
May 04, 20262026 (Q1)0.630.690.86-20.00% (-0.17)
Feb 23, 20262025 (Q4)0.15-0.220.58-137.50% (-0.80)
Oct 27, 20252025 (Q3)-0.25-0.140.5-129.09% (-0.64)
Aug 04, 20252025 (Q2)0.781.110.5123.64% (+0.61)
May 01, 20252025 (Q1)0.650.860.42106.52% (+0.44)
Feb 19, 20252024 (Q4)0.480.580.1481.82% (+0.48)
Oct 29, 20242024 (Q3)0.480.500.19161.90% (+0.31)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed